MiNK Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:INKT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -1.34 M-1.57 M-941.35 K-2.07 M-1.73 M-2.08 M -6.83 M Cash from investing activities —————— — Cash from financing activities 57654013.55 M1.18 M-2.1 M1.37 M 13.99 M Free cash flow -1.34 M-1.57 M-941.35 K-2.07 M-1.73 M-2.08 M -6.83 M

News

Here's Why You Should Add INKT Stock to Your Portfolio Now

MiNK Therapeutics, Inc. (INKT) Q1 2026 Earnings Call Transcript

MiNK Therapeutics, Inc. (INKT) Q4 2025 Earnings Call Transcript

MiNK Therapeutics stock soars 80% on C-Further collaboration

MiNK Therapeutics to begin phase 1 trial of iNKT cell therapy for GvHD

Ryvyl, NeoGenomics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Agilon Health (NYSE:AGL), Ambiq Micro (NYSE:AMBQ)

MiNK Therapeutics, Inc. (INKT) Q3 2025 Earnings Call Transcript

MiNK reports durable responses with iNKT cell therapy in resistant tumors

New Strong Sell Stocks for August 22nd

MiNK Therapeutics stock rating upgraded to Buy by H.C. Wainwright on financial results

MiNK Therapeutics, Inc. (INKT) Q2 2025 Earnings Call Transcript

MiNK Therapeutics Extends Cash Runway